HEXPOL Acquire Leading European Manufacturer of Thermoplastic Elastomers

HEXPOL has come to an agreement with the VITA Group to acquire VTC TPE Group.

VTC TPE Group is a leading developer and manufacturer of thermoplastic elastomer compounds (TPE Compounding) and has production units in Great Britain and Sweden.

"The acquisition constitutes yet another step in our ambition to broaden our product range within our Compounding business area" says Georg Brunstam, President and CEO of HEXPOL Group. "The market for TPE compounding is undergoing great growth with interesting and increasing customer applications within the field of medical, industry and automotive."

VTC TPE Group is expected to be consolidated as of 1 April 2010 and has an estimated annual turnover of approximately 33 MEUR with around 85 employees. The acquired group has an EBITDA margin in line with HEXPOL's and is expected to have a positive impact on earnings per share from the start. The acquisition price adjusted for acquired net debt amounts to 35 MEUR.

HEXPOL is a world-leading polymers group with strong global positions in advanced rubber compounds (Compounding), gaskets for plate heat exchangers (Gaskets) and wheels made of plastic and rubber materials for truck and castor wheel applications (Wheels). Customers are primarily OEM manufacturers of plate heat exchangers and trucks, as well as global systems suppliers to the automotive industry. The Group is organized in two business areas, HEXPOL Compounding and HEXPOL Engineered Products, and had about 1,800 employees in nine countries at year-end. In 2009, HEXPOL had sales of about 2,600 MSEK.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.